Robert L. Myers is CFO at Predictive Oncology Inc. (POAI). They have made 5 open-market trades across 3 companies since 2013, most recently 2023-09-25.
CIK 0001553600
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $12K since 2013, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| POAI | BUY | 2022-12-02 | 2022-12-02 | $0.57 | $5K | -29.3% | -45.4% | -26.2% |
| POAI | BUY | 2022-05-20 | 2022-05-20 | $0.30 | $5K | +40.7% | +47.1% | +48.6% |
| SKLN | BUY | 2014-09-15 | 2014-09-15 | $0.13 | $650 | N/A | N/A | N/A |
| SKLN | BUY | 2014-08-22 | 2014-08-22 | $0.15 | $750 | N/A | N/A | N/A |
| BIOR | BUY | 2013-03-08 | 2013-03-11 | $0.08 | $500 | -40.4% | -13.2% | -13.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.